Adjusted EPS -12% to $19.30, EBITDA -7% to $2.9B
Syngenta's earnings were hurt by reduced trait royalty income, a rise of $175M in seed production expenses following the U.S. drought in 2012, and a seeds inventory write-down of $170M.
The company intends to intensify its focus on "cost and capital efficiency" and plans to cut $1B a year by 2018.
Syngenta intends to increase its dividend 5% to 10 Swiss francs ($11.06) per share.
Syngenta expects 2014 integrated sales to increase at a similar rate to 2013. CEO Mike Mack said the company remains on course to reach its sales target of $25B by 2020. However, the firm forecasts that it will achieve the lower end of its target-margin range in 2015. (PR)